These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34422708)

  • 1. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study.
    Wan J; Wang X; Zhang Y; Xue X; Li Y; Liu Z; Han S; Chen M; Nie Y; Shi Y; Liang J; Wu K
    Can J Gastroenterol Hepatol; 2021; 2021():1412663. PubMed ID: 34422708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Pharmacologic Interventions for Preventing Recurrence of Crohn's Disease After Ileocolonic Surgery.
    Ong MS; Grand RJ; Mandl KD
    Inflamm Bowel Dis; 2016 Oct; 22(10):2432-41. PubMed ID: 27631599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea.
    Kim HJ; Oh SH; Lee SH; Kim YB; Kim DY; Park SH; Ye BD; Yang SK; Kim KM
    Gut Liver; 2021 Nov; 15(6):851-857. PubMed ID: 33833134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
    Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
    J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
    Ollech JE; Aharoni-Golan M; Weisshof R; Normatov I; Sapp AR; Kalakonda A; Israel A; Glick LR; Karrison T; Dalal SR; Sakuraba A; Cohen RD; Rubin DT; Pekow J
    Gastrointest Endosc; 2019 Aug; 90(2):269-275. PubMed ID: 30738034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy.
    Castillo-Regalado E; Ríos R; Aràjol C; Gely C; Márquez L; Calafat M; González-Muñoza C; Cañete F; Mesonero F; Guardiola J; Garcia-Planella E; Mañosa M; Domènech E
    Gastroenterol Hepatol; 2023 Mar; 46(3):164-170. PubMed ID: 36179946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.
    Arora U; Kedia S; Garg P; Bopanna S; Jain S; Yadav DP; Goyal S; Gupta V; Sahni P; Pal S; Dash NR; Madhusudhan KS; Sharma R; Makharia G; Ahuja V
    Dig Dis Sci; 2018 Jun; 63(6):1592-1599. PubMed ID: 29611078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated colonic Crohn's disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease.
    Xu Y; Guo Z; Cao L; Xie T; Shen W; Li Y; Gong J; Zhu W
    Clin Nutr; 2019 Aug; 38(4):1629-1635. PubMed ID: 30193873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.
    Schreiber S; Howaldt S; Raedler A
    Gut; 1994 Aug; 35(8):1081-5. PubMed ID: 7926910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease.
    de Franchis R; Omodei P; Ranzi T; Brignola C; Rocca R; Prada A; Pera A; Vecchi M; Del Piano M; Ferrara A; Belloli C; Piodi L; Framarin L; Astegiano M; Riccioli FA; Meucci G
    Aliment Pharmacol Ther; 1997 Oct; 11(5):845-52. PubMed ID: 9354191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists.
    Gearry RB; Ajlouni Y; Nandurkar S; Iser JH; Gibson PR
    Inflamm Bowel Dis; 2007 Aug; 13(8):1009-15. PubMed ID: 17352386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
    Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
    Morar PS; Hodgkinson JD; Thalayasingam S; Koysombat K; Purcell M; Hart AL; Warusavitarne J; Faiz O
    J Crohns Colitis; 2015 Jun; 9(6):483-91. PubMed ID: 25796553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.
    Louis E; Collard A; Oger AF; Degroote E; Aboul Nasr El Yafi FA; Belaiche J
    Gut; 2001 Dec; 49(6):777-82. PubMed ID: 11709511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bowel Stiffness Assessed by Shear-Wave Ultrasound Elastography Predicts Disease Behavior Progression in Patients With Crohn's Disease.
    Chen YJ; He JS; Xiong SS; Li MY; Chen SL; Chen BL; Qiu Y; Xia QQ; He Y; Zeng ZR; Chen MH; Xie XY; Mao R
    Clin Transl Gastroenterol; 2024 Apr; 15(4):e00684. PubMed ID: 38270207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
    Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
    J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.
    Thia KT; Sandborn WJ; Harmsen WS; Zinsmeister AR; Loftus EV
    Gastroenterology; 2010 Oct; 139(4):1147-55. PubMed ID: 20637205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.